Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma von Shao, Yu‐Yun, Liu, Tsung‐Hao, Hsu, Chiun, Lu, Li‐Chun, Shen, Yin‐Chung, Lin, Zhong‐Zhe, Cheng, Ann‐Lii, Hsu, Chih‐Hung

Volltext

Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma von Chen, Ching-Tso, Liu, Tsung-Hao, Shao, Yu-Yun, Liu, Kao-Lang, Liang, Po-Chin, Lin, Zhong-Zhe

Volltext

Novel systemic therapy for hepatocellular carcinoma von Dong, Yawen, Liu, Tsung-Hao, Yau, Thomas, Hsu, Chiun

Volltext

Immune checkpoint inhibitors for hepatocellular carcinoma – A game changer in treatment landscape von Liu, Tsung-Hao, Shen, Ying-Chun, Cheng, Ann-Lii

Volltext

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective von Su, Tung-Hung, Wu, Chih-Horng, Liu, Tsung-Hao, Ho, Cheng-Maw, Liu, Chun-Jen

Volltext

Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3 von CHEN, Kuen-Feng, TAI, Wei-Tien, LIU, Tsung-Hao, HUANG, Hsiang-Po, LIN, Yu-Chin, SHIAU, Chung-Wai, LI, Pui-Kai, CHEN, Pei-Jer, CHENG, Ann-Lii

Volltext

It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade von Liu, Tsung-Hao, Shao, Yu-Yun, Hsu, Chih-Hung

Volltext

Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study von Lee, Meng-Rui, Yu, Kai-Lun, Kuo, Hung-Yang, Liu, Tsung-Hao, Ko, Jen-Chung, Tsai, Jaw-Shiun, Wang, Jann-Yuan

Volltext

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma von Lu, Li-Chun, Hsu, Chiun, Shao, Yu-Yun, Chao, Yee, Yen, Chia-Jui, Shih, I-Lun, Hung, Yi-Ping, Chang, Chun-Jung, Shen, Ying-Chun, Guo, Jhe-Cyuan, Liu, Tsung-Hao, Hsu, Chih-Hung, Cheng, Ann-Lii

Volltext

Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma von Shao, Yu-Yun, Liu, Tsung-Hao, Lee, Ying-Hui, Hsu, Chih-Hung, Cheng, Ann-Lii

Volltext

Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation von Chen, Kuen-Feng, Yu, Hui-Chuan, Liu, Tsung-Hao, Lee, Shoei-Sheng, Chen, Pei-Jer, Cheng, Ann-Lii

Volltext

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy von Shen, Ying-Chun, Yeh, Ching-Ping, Jeng, Yung-Ming, Hsu, Chiun, Hsu, Chih-Hung, Lin, Zhong-Zhe, Shao, Yu-Yun, Lu, Li-Chun, Liu, Tsung-Hao, Chen, Chien-Hung, Cheng, Ann-Lii

Volltext

Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma von Chen, Bang-Bin, Liang, Po-Chin, Shih, Tiffany Ting-Fang, Liu, Tsung-Hao, Shen, Ying-Chun, Lu, Li-Chun, Lin, Zhong-Zhe, Hsu, Chiun, Hsu, Chih-Hung, Cheng, Ann-Lii, Shao, Yu-Yun

Volltext

Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment von Lu, Li-Chun, Lee, Yi-Hsuan, Chang, Chun-Jung, Shun, Chia-Tung, Fang, Chih-Yeu, Shao, Yu-Yun, Liu, Tsung-Hao, Cheng, Ann-Lii, Hsu, Chih-Hung

Volltext

Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression von Liu, Tsung-Hao, Chen, San-Chi, Rau, Kun-Ming, Lu, Li-Chun, Lin, Po-Ting, Su, Yung-Yeh, Teng, Wei, Lai, Shiue-Wei, Yeh, Ren-Hua, Kao, Tsui-Mai, Lee, Pei-Chang, Wu, Chi-Jung, Chen, Chien-Hung, Hsu, Chih-Hung, Lin, Shi-Ming, Huang, Yi-Hsiang, Chen, Li-Tzong, Cheng, Ann-Lii, Shen, Ying-Chun

Volltext

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma von Shen, Ying-Chun, Lee, Pei-Chang, Kuo, Yu-Lun, Wu, Wei-Kai, Chen, Chieh-Chang, Lei, Chengh-Hau, Yeh, Ching-Ping, Hsu, Chiun, Hsu, Chih-Hung, Lin, Zhong-Zhe, Shao, Yu-Yun, Lu, Li-Chun, Liu, Tsung-Hao, Chen, Chien-Hung, Wu, Ming-Shiang, Huang, Yi-Hsiang, Cheng, Ann-Lii

Volltext

Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure von Liu, Tsung-Hao, Hsu, Chih-Hung, Shao, Yu-Yun

Volltext

Perivascular epithelioid cell tumor of the gastrointestinal tract von Liu, Tsung-Hao, Liang, Cher-Wei, Lu, Li-Chun

Volltext

Minimum cycle bases of weighted outerplanar graphs von Liu, Tsung-Hao, Lu, Hsueh-I

Volltext

MO6-2 Regorafenib plus tislelizumab as first-line systemic therapy for patients with advanced hepatocellular carcinoma (HCC) von Chuang, Chienhuai, Liu, Tsung-Hao, Hsu, Meng-Chi, Chang, Mo-Jung, Cheng, Ann-Lii, Hsu, Chiun

Volltext